https://youtu.be/xL_nlERmIDQ Key highlights from Syngene International Ltd (SYNGENE) Q1 FY23 Earnings Concall Q&A Highlights: Prakash Agarwal from Axis Capital asked about the
Syngene International Ltd Q1 FY23 Earnings Conference Call Insights
Categories
Health Care
Gland Pharma Limited (GLAND) Q1 FY23 Earnings Concall Transcript
Gland Pharma Limited (NSE: GLAND) Q1 FY23 Earnings Concall dated Jul. 20, 2022 Corporate Participants: Sumanta Bajpayee -- Vice President, Corporate Finance and Investor
Gland Pharma Limited Q1 FY23 Earnings Conference Call Insights
https://youtu.be/wKPiFWdsaFY Key highlights from Gland Pharma Limited (GLAND) Q1 FY23 Earnings Concall Management Update: GLAND said it is experiencing increased attrition and
Gland Pharma Ltd. for Q1FY23 reports a 35% fall in Profits
Revenue has fell by 26% YoY to ₹8,569 millions. Core Market Revenue has decreased by 6% and Rest of the world revenue
Gland Pharma Limited (GLAND) Q1 FY23 Earnings Concall Transcript
Gland Pharma Limited (NSE:GLAND) Q1 FY23 Earnings Concall dated Jul. 20, 2022 Corporate Participants: Sumanta Bajpayee -- Vice President, Corporate Finance and Investor
ICICI Lombard General Insurance Company Limited (ICICIGI) Q1 FY23 Earnings Concall Transcript
ICICI Lombard General Insurance Company Limited (NSE:ICICIGI)Q1 FY23 Earnings Concall dated Jul. 19, 2022 Corporate Participants: Bhargav Dasgupta -- Managing Director &
Krsnaa Diagnostics Ltd Q4 FY22 Earnings Conference Call Insights
https://youtu.be/oafWwDciC8w Key highlights from Krsnaa Diagnostics Ltd (KRSNAA) Q4 FY22 Earnings Concall Q&A Highlights: Praveen Sahay of Edelweiss asked that why the
IOL Chemicals and Pharmaceuticals Limited Q4 FY22 Earnings Conference Call Insights
https://youtu.be/HCB5WuVf8_E Key highlights from IOL Chemicals and Pharmaceuticals Limited (IOLCP) Q4 FY22 Earnings Concall Management Update: IOLCP is optimistic on its
Marksans Pharma Limited Q4 FY22 Earnings Conference Call Insights
Key highlights from Marksans Pharma Limited (MARKSANS) Q4 FY22 Earnings Concall Q&A Highlights: Vijay Nahar - Individual Investor - Analyst Challenges
Lupin Ltd Q4 FY22 Earnings Conference Call Insights
https://youtu.be/KuHcJgOThAg Key highlights from Lupin Ltd (LUPIN) Q4 FY22 Earnings Concall Q&A Highlights: Pritesh Vora - Mission Street India - Analyst
SMS Pharmaceuticals Ltd Q4 FY22 Earnings Conference Call Insights
Key highlights from SMS Pharmaceuticals Ltd (SMSPHARMA) Q4 FY22 Earnings Concall Management Update: SMSPHARMA said its near-term focus remains on scaling up
Apollo Hospitals Q4 FY22 Earnings Conference Call Insights
https://youtu.be/o39b8VAmN3k Key highlights from Apollo Hospitals (APOLLOHOSP) Q4 FY22 Earnings Concall Q&A Highlights: Anubhav Aggarwal from Credit Suisse asked what impacted the
Torrent Pharmaceuticals Ltd (TORNTPHARM) Q4 FY22 Earnings Concall Transcript
Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM) Q4 FY22 Earnings Concall dated May. 25, 2022 Corporate Participants: Sudhir Menon -- Executive Director and Chief Financial
MedPlus Health Services Ltd Q4 FY22 Earnings Conference Call Insights
https://youtu.be/9lLLmPN__Yo Key highlights from MedPlus Health Services Ltd (MEDPLUS) Q4 FY22 Earnings Concall Management Update: MEDPLUS said it opened 288 stores in
Aurobindo Pharma Limited Q4 FY22 Earnings Conference Call Insights
https://youtu.be/ZZNGEHlRimc Key highlights from Aurobindo Pharma Limited (AUROPHARMA) Q4 FY22 Earnings Concall Management Update: AUROPHARMA received final approval for 3 ANDAs and
Hikal Limited Q4 FY22 Earnings Conference Call Insights
https://youtu.be/3z2q_SR1OS4 Key highlights from Hikal Limited (HIKAL) Q4 FY22 Earnings Concall Management Update: HIKAL said its new product launches in anti-diabetic have
Hikal Limited (HIKAL) Q4 FY22 Earnings Concall Transcript
Hikal Limited (NSE: HIKAL) Q4 FY22 Earnings Concall dated Jun. 03, 2022 Corporate Participants: Anish Swadi -- Senior President of Animal Health and Business
Glenmark Pharmaceuticals Limited Q4 FY22 Earnings Conference Call Insights
https://youtu.be/uTUQ9VpSoiU Key highlights from Glenmark Pharmaceuticals Limited (GLENMARK) Q4 FY22 Earnings Concall Management Update: GLENMARK said the India business continues to significantly
Piramal Enterprises Ltd Q4 FY22 Earnings Conference Call Insights
Key highlights from Piramal Enterprises Ltd (PEL) Q4 FY22 Earnings Concall Management Update: Over the next five years, PEL aspire to achieve
Torrent Pharmaceuticals Ltd Q4 FY22 Earnings Conference Call Insights
Key highlights from Torrent Pharmaceuticals Ltd (TORNTPHARM) Q4 FY22 Earnings Concall Q&A Highlights: Anubhav Aggarwal of Credit Suisse asked about Brazil market,
Supriya Lifescience Ltd Q4 FY22 Earnings Conference Call Insights
https://youtu.be/VIL70Aj2g04 Key highlights from Supriya Lifescience Ltd (SUPRIYA) Q4 FY22 Earnings Concall Management Update: SUPRIYA said that going forward the company’s focus